News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,309 Results
Type
Article (8077)
Company Profile (140)
Press Release (476091)
Multimedia
Podcasts (5)
Webinars (6)
Section
Business (166803)
Career Advice (307)
Deals (25750)
Drug Delivery (7)
Drug Development (52911)
Employer Resources (14)
FDA (9767)
Job Trends (8581)
News (238324)
Policy (17955)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (484)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33164)
ALS (104)
Alzheimer's disease (972)
Antibody-drug conjugate (ADC) (265)
Approvals (10369)
Artificial intelligence (317)
ASCO (160)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6960)
BIO (37)
BIOSECURE Act (1)
Biosimilars (108)
BioSpace Insights (19)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (508)
Cancer (3627)
Cardiovascular disease (218)
Career advice (246)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (474)
Cervical cancer (34)
Clinical research (47846)
Collaboration (1238)
Commercialization (2)
Compensation (1436)
Complete response letters (34)
COVID-19 (755)
CRISPR (63)
C-suite (732)
Cystic fibrosis (85)
Data (5589)
Denatured (5)
Depression (102)
Dermatology (60)
Diabetes (339)
Diagnostics (4174)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73478)
Editorial (2)
Employer branding (2)
Employer resources (14)
Events (87593)
Executive appointments (695)
FDA (12362)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (902)
Gene editing (125)
Generative AI (9)
Gene therapy (315)
GLP-1 (290)
Government (943)
Grass and pollen (2)
Guidances (282)
Healthcare (9312)
Hematology (95)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (155)
Infectious disease (943)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (250)
Interviews (41)
IPO (12388)
IRA (2)
Job creations (1970)
Job search strategy (236)
JPM (1)
Kidney cancer (16)
Layoffs (61)
Legal (5196)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (502)
Lymphoma (248)
Machine learning (27)
Management (3)
Manufacturing (524)
Marketing (7)
MASH (117)
Medical device (8649)
Medtech (8787)
Mergers & acquisitions (14382)
Metabolic disorders (699)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (218)
Neuropsychiatric disorders (38)
Neuroscience (1812)
NextGen: Class of 2026 (3152)
Non-profit (843)
Obesity (221)
Opinion (11)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (200)
Partnered (11)
Patents (465)
Patient recruitment (497)
Peanut (31)
People (41198)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15454)
Phase 2 (21365)
Phase 3 (14396)
Pipeline (7022)
Policy (18)
Postmarket research (1570)
Preclinical (6534)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (190)
Rare diseases (571)
Real estate (3021)
Recruiting (6)
Regulatory (14796)
Reports (18)
Research institute (579)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (152)
Series B (119)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (4)
Supply chain (50)
Vaccines (318)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Today (86)
Last 7 days (540)
Last 30 days (1487)
Last 365 days (19125)
2026 (11715)
2025 (19264)
2024 (22994)
2023 (26546)
2022 (34638)
2021 (37213)
2020 (33481)
2019 (23258)
2018 (17471)
2017 (18772)
2016 (17917)
2015 (24269)
2014 (21679)
2013 (18138)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (228)
Alabama (72)
Alaska (2)
Arizona (299)
Arkansas (11)
Asia (17944)
Australia (2096)
California (11798)
Canada (3097)
China (513)
Colorado (476)
Connecticut (402)
Delaware (206)
Europe (24651)
Florida (1762)
Georgia (370)
Hawaii (3)
Idaho (46)
Illinois (691)
India (45)
Indiana (314)
Iowa (14)
Japan (395)
Kansas (99)
Kentucky (30)
Louisiana (26)
Maine (25)
Maryland (1181)
Massachusetts (7775)
Michigan (305)
Minnesota (556)
Mississippi (4)
Missouri (79)
Montana (20)
Nebraska (11)
Nevada (113)
New Hampshire (60)
New Jersey (2590)
New Mexico (12)
New York (2787)
North Carolina (1256)
North Dakota (4)
Northern California (5897)
Ohio (273)
Oklahoma (14)
Oregon (16)
Pennsylvania (2231)
Puerto Rico (20)
Rhode Island (30)
South America (407)
South Carolina (76)
South Dakota (1)
Southern California (4898)
Tennessee (117)
Texas (1902)
United States (38354)
Utah (357)
Vermont (1)
Virginia (151)
Washington D.C. (38)
Washington State (911)
West Virginia (1)
Wisconsin (73)
484,309 Results for "zymeworks inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Zymeworks adds lung disease drug, royalty deals in nearly $1B pick up of Theravance
Zymeworks announced a new plan to become a royalty-driven company last year, making Theravance a perfect match.
June 29, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Zymeworks to Acquire Theravance Biopharma, Inc.
June 29, 2026
·
17 min read
Press Releases
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 7, 2026
·
24 min read
Cancer
AACR 2026: Moderna, Revolution, Zymeworks and BeOne showcase new data
Moderna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses at head and neck cancer.
April 21, 2026
·
4 min read
·
Tristan Manalac
Press Releases
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
July 16, 2026
·
2 min read
Press Releases
Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery
June 18, 2026
·
3 min read
Press Releases
Zymeworks Announces Participation in Upcoming Investor Conferences - May 13, 2026
May 13, 2026
·
2 min read
Press Releases
Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 8, 2026
·
24 min read
Press Releases
Zymeworks Appoints Kristin Stafford as Chief Financial Officer
April 1, 2026
·
7 min read
Press Releases
Zymeworks Announces Participation in Upcoming April 2026 Investor Conferences
March 24, 2026
·
2 min read
1 of 48,431
Next
